Life Sciences Innovation
Let’s leverage innovation to cure cancer, to live longer and better lives, to design new ground-breaking drugs, to make more sustainable materials for our products and new fuels for our machines. Innovations in the life sciences are some of the most exciting on the planet.
Financing life sciences
Throughout human history, we have dreamed of a world where no loved ones are lost to cruel diseases, where sight is given to the blind, and where every child grows up healthy. Now, innovation in the life sciences offers us the chance to make this dream a reality.
FTL is a global private equity firm that invests in the most challenging and exciting projects in the life sciences. We believe these companies have the potential to dramatically improve human life time and again.
Our approach removes the traditional barriers between innovation and progress, providing the finance life sciences companies need to complete the final stages of commercializing their innovation.
- Phase II clinical trials
- Phase III clinical trials
- Gene editing
- Personalized medicine
- In vitro diagnostics
The Catalyst for Innovation
We believe that companies in the life sciences will define the future of humanity. However, to do so, they require capital alongside strategic guidance that maximizes innovation and returns on investment.
Working collaboratively with our portfolio companies and their investors, we mitigate risk and create bespoke capital solutions, providing finance where it was previously impossible.
Our team combines decades of experience in both the life sciences and capital markets, and understands the challenges that innovative companies face. We believe that our capital and industry specific knowledge can be the catalyst behind your innovation.